In Brief: PolyPid’s D-PLEX100 Aces Phase III Trial, US Partner, Submission Eyed

Second Time Lucky

 
• By Sushmita Panda

PolyPid's D-PLEX100 meets Phase III endpoints this time around, significantly reducing surgical point infections in abdominal colorectal surgery, and is set for a US approval submission early next year.

PolyPid seeking US partner for lead candidate D-PLEX100 for post-surgery infections.  • Source: Shutterstock

More from Clinical Trials

More from Therapy Areas